Abstract
This study aims to investigate the changing patterns of the burden for atrial fibrillation (AF)/atrial flutter (AFL) attributed to high systolic blood pressure (SBP) in China. Data were sourced from the Global Burden of Disease (GBD) 2021 project. The disease burden of AF/AFL attributed to high SBP in China from 1990 to 2021 was analyzed stratified by sex and age, along with the trend prediction from 2022 to 2050. In China, between 1990 and 2021, the age-standardized mortality rate (ASMR) and the age-standardized disability-adjusted life years (DALYs) rate (ASDR) of AF/AFL attributable to high SBP in male have been increasing, and the trend will continue till 2050, whereas in female, the trend is slightly downward. Globally, however, the disease burden according to the estimated annual percentage changes (EAPC) of ASMR and ASDR presents a decreasing trend in both genders between 1990 and 2021. The main driver of the increased DALY burden for AF/AFL attributed to high SBP is population aging. In China, the disease burden of AF/AFL attributable to high SBP in male has been increasing between 1990 and 2021 and keeps an upward trend till 2050, whereas in female, the trend is slightly downward. Our research implies that the public health decision-making needs to give sufficient attention to alleviate the burden of AF /AFL attributable to high SBP in China by promoting awareness, treatment, and controlling rates of hypertension, especially in male.

This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout






Similar content being viewed by others
Data availability
The datasets generated and analyzed in the current study are available at GBD 2021 website: https://ghdx.healthdata.org/gbd-results-tool.
References
Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns H, et al. 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024;https://doi.org/10.1093/eurheartj/ehae176.
GBD 2017 Population and Fertility CollaboratorsPopulation and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1995–2051.
Shi S, Tang Y, Zhao Q, Yan H, Yu B, Zheng Q, et al. Prevalence and risk of atrial fibrillation in China: a national cross-sectional epidemiological study. Lancet Reg Health West Pac. 2022;23:100439.
Nazarzadeh M, Pinho-Gomes AC, Bidel Z, Canoy D, Dehghan A, Smith Byrne K, et al. Genetic susceptibility, elevated blood pressure, and risk of atrial fibrillation: a Mendelian randomization study. Genome Med. 2021;13:38.
Li Y, Wang DD, Ley SH, Howard AG, He Y, Lu Y, et al. Potential impact of time trend of lifestyle factors on cardiovascular disease burden in China. J Am Coll Cardiol. 2016;68:818–33.
Li YG, Pastori D, Farcomeni A, Yang PS, Jang E, Joung B, et al. A simple clinical risk score (C(2)HEST) for predicting incident atrial fibrillation in asian subjects: derivation in 471,446 chinese subjects, with internal validation and external application in 451,199 Korean subjects. Chest. 2019;155:510–8.
Wang Z, Chen Z, Zhang L, Wang X, Hao G, Zhang Z, et al. Status of hypertension in China: Results from the China Hypertension Survey, 2012-2015. Circulation. 2018;137:2344–56.
Nie Z, Xu H, Chen C, Gan Y, Chen G, Wang C, et al. Population attributable risks of potential modifiable factors for atrial fibrillation in China: a National Survey. Risk Manag Health Policy. 2022;15:1215–24.
Diseases GBD, Injuries C. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403:2133–61.
Brauer M, Roth GA, Aravkin AY, Zheng P, Abate KH, Abate YH, et al. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403:2162–203.
Hankey BF, Ries LA, Kosary CL, Feuer EJ, Merrill RM, Clegg LX, et al. Partitioning linear trends in age-adjusted rates. Cancer Causes Control. 2000;11:31–5.
GBD 2019 Dementia Forecasting CollaboratorsEstimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7:e105–e25.
Das Gupta P. A general method of decomposing a difference between two rates into several components. Demography. 1978;15:99–112.
Clayton D, Schifflers E. Models for temporal variation in cancer rates. II: age-period-cohort models. Stat Med. 1987;6:469–81.
Wang Y, Wang J, Chen S, Li B, Lu X, Li J. Different changing patterns for stroke subtype mortality attributable to high sodium intake in China during 1990 to 2019. Stroke. 2023;54:1078–87.
Rosenberg PS, Check DP, Anderson WF. A web tool for age-period-cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol Biomark Prev. 2014;23:2296–302.
Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet. 2018;392:2052–90.
Soliman EZ, Rahman AF, Zhang ZM, Rodriguez CJ, Chang TI, Bates JT, et al. Effect of intensive blood pressure lowering on the risk of atrial fibrillation. Hypertension. 2020;75:1491–6.
Verdecchia P, Angeli F, Reboldi G. Hypertension and atrial fibrillation: doubts and certainties from basic and clinical studies. Circ Res. 2018;122:352–68.
Lawes CM, Rodgers A, Bennett DA, Parag V, Suh I, Ueshima H, et al. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens. 2003;21:707–16.
Du S, Wang H, Zhang B, Popkin BM. Dietary potassium intake remains low and sodium intake remains high, and most sodium is derived from home food preparation for chinese adults, 1991–2015 trends. J Nutr. 2020;150:1230–9.
Zhang M, Shi Y, Zhou B, Huang Z, Zhao Z, Li C, et al. Prevalence, awareness, treatment, and control of hypertension in China, 2004–18: findings from six rounds of a national survey. BMJ. 2023;380:e071952.
Ma S, Yang L, Zhao M, Magnussen CG, Xi B. Trends in hypertension prevalence, awareness, treatment and control rates among Chinese adults, 1991–2015. J Hypertens. 2021;39:740–8.
Kawabe H, Azegami T, Takeda A, Kanda T, Saito I, Saruta T, et al. Features of and preventive measures against hypertension in the young. Hypertens Res. 2019;42:935–48.
Yin R, Yin L, Li L, Silva-Nash J, Tan J, Pan Z, et al. Hypertension in China: burdens, guidelines and policy responses: a state-of-the-art review. J Hum Hypertens. 2022;36:126–34.
Westerman S, Wenger N. Gender differences in atrial fibrillation: a review of epidemiology, management, and outcomes. Curr Cardiol Rev. 2019;15:136–44.
Colafella KMM, Denton KM. Sex-specific differences in hypertension and associated cardiovascular disease. Nat Rev Nephrol. 2018;14:185–201.
Kim JS, Shin SY, Kang JH, Yong HS, Na JO, Choi CU, et al. Influence of sex on the association between epicardial adipose tissue and left atrial transport function in patients with atrial fibrillation: a multislice computed tomography study. J Am Heart Assoc. 2017;6:e006077.
Olesen JB, Lip GY, Hansen ML, Hansen PR, Tolstrup JS, Lindhardsen J, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ. 2011;342:d124.
Nielsen PB, Brondum RF, Nohr AK, Overvad TF, Lip GYH. Risk of stroke in male and female patients with atrial fibrillation in a nationwide cohort. Nat Commun. 2024;15:6728.
Zhao QY, Shi SB, Huang H, Jiang H, Yang B, Wu G, et al. Contemporary characteristics, management, and outcomes of patients hospitalized for atrial fibrillation in China: results from the real-world study of Chinese atrial fibrillation registry. Chin Med J. 2020;133:2883–4.
Gu HQ, Yang X, Wang CJ, Zhao XQ, Wang YL, Liu LP, et al. Assessment of trends in guideline-based oral anticoagulant prescription for patients with ischemic stroke and atrial fibrillation in China. JAMA Netw Open. 2021;4:e2118816.
Wang JR, Du X, Dong JZ, Chang SS, Jiang C, Sang CH, et al. Use of oral anticoagulants and its associated factors among nonvalvular atrial fibrillation patients with new-onset acute ischemic stroke: a report from the China Atrial Fibrillation Registry study. Clin Cardiol. 2022;45:60–7.
Dong XJ, Wang BB, Hou FF, Jiao Y, Li HW, Lv SP, et al. Global burden of atrial fibrillation/atrial flutter and its attributable risk factors from 1990 to 2019. Europace. 2023;25:793–803.
Dagres N, Nieuwlaat R, Vardas PE, Andresen D, Levy S, Cobbe S, et al. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol. 2007;49:572–7.
Tian XT, Xu YJ, Yang YQ. Gender differences in arrhythmias: focused on atrial fibrillation. J Cardiovasc Transl Res. 2020;13:85–96.
Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015;386:154–62.
Gao P, Gao X, Xie B, Tse G, Liu T. Aging and atrial fibrillation: a vicious circle. Int J Cardiol. 2024;395:131445.
Hu FB, Liu Y, Willett WC. Preventing chronic diseases by promoting healthy diet and lifestyle: public policy implications for China. Obes Rev. 2011;12:552–9.
He Y, Li Y, Yang X, Hemler EC, Fang Y, Zhao L, et al. The dietary transition and its association with cardiometabolic mortality among Chinese adults, 1982–2012: a cross-sectional population-based study. Lancet Diab Endocrinol. 2019;7:540–8.
Hipgrave DB, Chang S, Li X, Wu Y. Salt and sodium intake in China. JAMA. 2016;315:703–5.
Noh B, McCullough LD, Moruno-Manchon JF. Sex-biased autophagy as a potential mechanism mediating sex differences in ischemic stroke outcome. Neural Regen Res. 2023;18:31–7.
Ramirez LA, Sullivan JC. Sex differences in hypertension: where we have been and where we are going. Am J Hypertens. 2018;31:1247–54.
Loo G, Puar T, Foo R, Ong TK, Wang TD, Nguyen QN, et al. Unique characteristics of Asians with hypertension: what is known and what can be done?. J Hypertens. 2024;42:1482–9.
Acknowledgements
We extend our sincere thanks to the contributors of the GBD 2021 and the Institute for Health Metrics and Evaluation (IHME) for their invaluable work. The study funders did not participate in the study’s design, data collection, analysis, interpretation, or report writing.
Funding
This study was supported by the National Natural Science Foundation of China [grant number: 82170247] and the Key Research Center Construction Project of Shanghai(2022ZZ01008).
Author information
Authors and Affiliations
Contributions
JL and XJ designed the study. LB and WJ analyzed the data, performed statistical analyses, and drafted the initial manuscript. JL and XJ checked and corrected the statistical analyses. YS, KYS, and HB modified the initial manuscript. All authors reviewed the drafted manuscript for critical content and approved the final version of the manuscript. The corresponding authors (JL and XJ) attest that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Liu, B., Wang, J., Yu, S. et al. Changing patterns of the burden for atrial fibrillation/atrial flutter attributable to high systolic blood pressure in China from 1990 to 2021. Hypertens Res (2025). https://doi.org/10.1038/s41440-025-02448-w
Received:
Revised:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41440-025-02448-w


